Full text loading...
View Affiliations Hide Affiliations
FN1Authors' addresses: Claudia R. Libertin, Division of Infectious Diseases, Mayo Clinic, Jacksonville, FL, and Department of Microbiology, Mayo Clinic Health System, Waycross, GA, E-mail: email@example.com. Mohammed Reza, Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, E-mail: firstname.lastname@example.org. Joy H. Peterson, Jason Lewis, and D. Jane Hata, Departments of Pathology and Laboratory Medicine, Mayo Clinic Health System, Waycross, GA, E-mails: email@example.com, firstname.lastname@example.org, and email@example.com.Notes
Disclaimer: Mayo Clinic does not endorse specific products or services included in this article.
- The American Society of Tropical Medicine and Hygiene
- Source: The American Journal of Tropical Medicine and Hygiene, Volume 96, Issue 4, Apr 2017, p. 873 - 875
Human Gongylonema pulchrum Infection: Esophageal Symptoms and Need for Prolonged Albendazole Therapy
We describe a case of human infection with Gongylonema pulchrum acquired in southeast Georgia. The patient presented with intermittent yet persistent nausea and vomiting for months. This case describes the need for extraction of worms on two occasions each followed by courses of albendazole treatment. Gongylonema pulchrum infections with high worm burden may relapse after extraction of the worm and a 3-day short course of albendazole therapy. Longer courses of albendazole may be indicated in selected circumstances.